466 related articles for article (PubMed ID: 8712783)
21. [Immunological tests: Anti-neutrophil cytoplasmic antibody].
Takizawa H
Nihon Rinsho; 2005 Jul; 63 Suppl 7():624-6. PubMed ID: 16111351
[No Abstract] [Full Text] [Related]
22. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.
Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D
Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976
[TBL] [Abstract][Full Text] [Related]
23. Clinical and pathological manifestations of patients with antineutrophil cytoplasmic autoantibodies directed against proteinase 3 or myeloperoxidase.
Zhang X; Dong Y; Zeng X; Li Y; Tang F
Chin Med Sci J; 2002 Mar; 17(1):32-5. PubMed ID: 12894882
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of anti-neutrophil cytoplasmic antibodies, anti-proteinase 3 and anti-myeloperoxidase in management of small vessel vasculitis].
Ara J; Mirapeix E; Rodríguez R; Pascual J; Alvarez L; Darnell A
Med Clin (Barc); 1998 Oct; 111(14):536-8. PubMed ID: 9859079
[TBL] [Abstract][Full Text] [Related]
25. What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.
Kallenberg CG; Tervaert JW
Curr Opin Nephrol Hypertens; 1999 May; 8(3):307-15. PubMed ID: 10456261
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis.
Damoiseaux JG; Slot MC; Vaessen M; Stegeman CA; Van Paassen P; Tervaert JW
J Clin Immunol; 2005 May; 25(3):202-8. PubMed ID: 15981084
[TBL] [Abstract][Full Text] [Related]
27. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
[TBL] [Abstract][Full Text] [Related]
28. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage.
Bosch X; López-Soto A; Mirapeix E; Font J; Ingelmo M; Urbano-Márquez A
Arch Pathol Lab Med; 1994 May; 118(5):517-22. PubMed ID: 7910729
[TBL] [Abstract][Full Text] [Related]
29. [Antineutrophilic cytoplasmic antibodies (ANCA) in inflammatory rheumatic diseases: immunodiagnostic and immunopathogenetic aspects].
Csernok E; Gross WL
Z Rheumatol; 1995; 54(1):26-38. PubMed ID: 7725808
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of PR3-ANCA associated vasculitis.
Kallenberg CG
J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
[TBL] [Abstract][Full Text] [Related]
31. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
Malenica B; Rudolf M; Kozmar A
Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
33. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
van der Geld YM; Stegeman CA; Kallenberg CG
Clin Exp Immunol; 2004 Sep; 137(3):451-9. PubMed ID: 15320893
[TBL] [Abstract][Full Text] [Related]
34. Variations in performance characteristics of commercial enzyme immunoassay kits for detection of antineutrophil cytoplasmic antibodies: what is the optimal cut off?
Holle JU; Hellmich B; Backes M; Gross WL; Csernok E
Ann Rheum Dis; 2005 Dec; 64(12):1773-9. PubMed ID: 15843447
[TBL] [Abstract][Full Text] [Related]
35. Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.
Tervaert JW; Limburg PC; Elema JD; Huitema MG; Horst G; The TH; Kallenberg CG
Am J Med; 1991 Jul; 91(1):59-66. PubMed ID: 1677531
[TBL] [Abstract][Full Text] [Related]
36. Antineutrophil cytoplasmic autoantibody testing in vasculitides.
Gross WL
Rheum Dis Clin North Am; 1995 Nov; 21(4):987-1011. PubMed ID: 8592745
[TBL] [Abstract][Full Text] [Related]
37. Alternating antineutrophil cytoplasmic antibody specificity: drug-induced vasculitis in a patient with Wegener's granulomatosis.
Choi HK; Merkel PA; Tervaert JW; Black RM; McCluskey RT; Niles JL
Arthritis Rheum; 1999 Feb; 42(2):384-8. PubMed ID: 10025935
[TBL] [Abstract][Full Text] [Related]
38. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
Russell KA; Fass DN; Specks U
Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
[TBL] [Abstract][Full Text] [Related]
39. Renal involvement in Wegener's granulomatosis.
Renaudineau Y; Le Meur Y
Clin Rev Allergy Immunol; 2008 Oct; 35(1-2):22-9. PubMed ID: 18172777
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides.
Jennette JC; Falk RJ
Am J Kidney Dis; 1991 Aug; 18(2):184-7. PubMed ID: 1867177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
